United States · FDA National Drug Code directory
Ovidrel
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 44087-1150_59d39f88-54fb-480a-979b-4d3d2c7c2cd4
- Product NDC
- 44087-1150
- Form
- INJECTION, SOLUTION
- Composition / generic term
- choriogonadotropin alfa
- Labeler
- EMD Serono, Inc.
- Marketing category
- BLA
- Marketing start / end (source format)
- 20031006
- Source listing expiry
- 20261231
Source-listed ingredients
- CHORIOGONADOTROPIN ALFA — 250 ug/.5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 SYRINGE, GLASS in 1 CARTON (44087-1150-1) / .5 mL in 1 SYRINGE, GLASS · 44087-1150-1
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →